ArticleHematology, transfusion and cell therapy

c.9253-6T>c REV3L: A novel marker of poor prognosis in Myelodysplastic syndrome.

Roberta Taiane G de Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.